coumarin has been researched along with Thromboembolism in 105 studies
2H-chromen-2-one: coumarin derivative
Thromboembolism: Obstruction of a blood vessel (embolism) by a blood clot (THROMBUS) in the blood stream.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We evaluated the effect of long-term anticoagulant treatment (enoxaparin vs coumarin) in patients with deep venous thrombosis (DVT) as to incidence of post-thrombotic syndrome (PTS) and recurrent venous thromboembolism." | 9.13 | Effect of the anticoagulant therapy in the incidence of post-thrombotic syndrome and recurrent thromboembolism: Comparative study of enoxaparin versus coumarin. ( Castrodeza, J; González-Fajardo, JA; Martin-Pedrosa, M; Tamames, S; Vaquero-Puerta, C, 2008) |
| "Survival data were examined in a posthoc analysis in patients with solid tumors and venous thromboembolism who were randomly assigned to dalteparin or a coumarin derivative for 6 months in a multicenter, open-label, randomized, controlled trial." | 9.11 | Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism. ( Baker, RI; Bowden, C; Gent, M; Julian, JA; Kakkar, AK; Lee, AY; Levine, MN; Prins, M; Rickles, FR, 2005) |
| "To investigate the effectiveness of aspirin and coumarin in preventing thromboembolism in patients with non-rheumatic atrial fibrillation in general practice." | 9.09 | Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirin. ( Hellemons, BS; Knottnerus, JA; Langenberg, M; Lemmens, T; Lodder, J; Schouten, HJ; van Ree, JW; Vermeer, F, 1999) |
| " with coumarin) is still the most widely used treatment for deep venous thromboembolism." | 9.07 | Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications to coumarin. ( del Rio, L; Lafoz, E; Monreal, M; Olive, A; Vedia, C, 1994) |
| "Defiency of protein C has been reported to be associated with recurrent thrombosis and pulmonary embolism, disseminated intravascular coagulation, and coumarin-induced skin necrosis and peripheral gangrene." | 7.67 | Recurrent thromboembolism, disseminated intravascular coagulation, and coumarin-induced skin necrosis associated with protein C deficiency. ( Lie, JT, 1988) |
| "Hemorrhagic skin necrosis of the toes was observed in a patient with heterozygous protein C deficiency (protein C:Ag 32% and protein C activity 30%) on the 4th day of coumarin treatment overlapping with effective intravenous anticoagulation with heparin." | 7.67 | Coumarin induced acral skin necrosis associated with hereditary protein C deficiency. ( Karnik, R; Lechner, K; Niessner, H; Pabinger, I; Slany, J, 1986) |
| "We evaluated the effect of long-term anticoagulant treatment (enoxaparin vs coumarin) in patients with deep venous thrombosis (DVT) as to incidence of post-thrombotic syndrome (PTS) and recurrent venous thromboembolism." | 5.13 | Effect of the anticoagulant therapy in the incidence of post-thrombotic syndrome and recurrent thromboembolism: Comparative study of enoxaparin versus coumarin. ( Castrodeza, J; González-Fajardo, JA; Martin-Pedrosa, M; Tamames, S; Vaquero-Puerta, C, 2008) |
| "Survival data were examined in a posthoc analysis in patients with solid tumors and venous thromboembolism who were randomly assigned to dalteparin or a coumarin derivative for 6 months in a multicenter, open-label, randomized, controlled trial." | 5.11 | Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism. ( Baker, RI; Bowden, C; Gent, M; Julian, JA; Kakkar, AK; Lee, AY; Levine, MN; Prins, M; Rickles, FR, 2005) |
| "To investigate the effectiveness of aspirin and coumarin in preventing thromboembolism in patients with non-rheumatic atrial fibrillation in general practice." | 5.09 | Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirin. ( Hellemons, BS; Knottnerus, JA; Langenberg, M; Lemmens, T; Lodder, J; Schouten, HJ; van Ree, JW; Vermeer, F, 1999) |
| " with coumarin) is still the most widely used treatment for deep venous thromboembolism." | 5.07 | Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications to coumarin. ( del Rio, L; Lafoz, E; Monreal, M; Olive, A; Vedia, C, 1994) |
| "Significant advances in the pharmacological prophylaxis of venous thromboembolism have occurred since warfarin and unfractionated heparin were introduced for this indication nearly 60 years ago." | 4.82 | Current options in the prevention of thromboembolic disease. ( Ansell, J; Bergqvist, D, 2004) |
| " Coumarin derivatives provide adequate protection against thromboembolism and should be used during pregnancy in patients with mechanical prostheses." | 4.81 | [Heart disease, anticoagulants and pregnancy]. ( Izaguirre, R; Salazar, E, 2001) |
| "The aim of the present study was to assess which clinical determinants influence coumarin and aspirin prescription in patients with atrial fibrillation in primary care." | 3.72 | Is treatment of atrial fibrillation in primary care based on thromboembolic risk assessment? ( Hak, E; Hoes, AW; Rutten, FH; Stalman, WA; Verheij, TJ, 2003) |
| " The major drawback of coumarin therapy is the increased risk of hemorrhage." | 3.72 | Lowering the intensity of oral anticoagulant therapy: effects on the risk of hemorrhage and thromboembolism. ( Rosendaal, FR; Torn, M; van der Meer, FJ, 2004) |
| "Defiency of protein C has been reported to be associated with recurrent thrombosis and pulmonary embolism, disseminated intravascular coagulation, and coumarin-induced skin necrosis and peripheral gangrene." | 3.67 | Recurrent thromboembolism, disseminated intravascular coagulation, and coumarin-induced skin necrosis associated with protein C deficiency. ( Lie, JT, 1988) |
| "Hemorrhagic skin necrosis of the toes was observed in a patient with heterozygous protein C deficiency (protein C:Ag 32% and protein C activity 30%) on the 4th day of coumarin treatment overlapping with effective intravenous anticoagulation with heparin." | 3.67 | Coumarin induced acral skin necrosis associated with hereditary protein C deficiency. ( Karnik, R; Lechner, K; Niessner, H; Pabinger, I; Slany, J, 1986) |
| "Aspirin has proved useful in further reducing thromboembolic events when added to oral anticoagulants." | 2.68 | Low-intensity oral anticoagulation plus low-dose aspirin versus high-intensity oral anticoagulation alone: a randomized trial in patients with mechanical prosthetic heart valves. ( Fondevila, CG; Frontroth, J; Lazzari, MA; Meschengieser, SS; Santarelli, MT, 1997) |
| "Authors studied the effect of coumarin, and its combination with low-dose (125 mg/day) acetylsalicylic acid in the prevention of thromboembolic complication during a 10-year period (average 4." | 2.68 | [Coumarin combined with low-dose acetylsalicylic acid in the prevention of thromboembolic complications in patients with mitral and aortic valve prostheses]. ( Boda, Z; Bódi, A; Csapó, K; Hegedús, I; Medgyesi, F; Pfliegler, G; Voith, L, 1997) |
| "We applied eight already existing acenocoumarol dosing algorithms to Bulgarian patients with low acenocoumarol dose requirements and investigated which of these algorithms would predict most precisely the dose anticoagulant." | 1.42 | Acenocoumarol Pharmacogenetic Dosing Algorithms and Their Application in Two Bulgarian Patients with Low Anticoagulant Requirements. ( Chilingirova, N; Dimitrova-Karamfilova, A; Goranova, T; Kaneva, R; Mitev, V; Nachev, G; Tzveova, R, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 71 (67.62) | 18.7374 |
| 1990's | 14 (13.33) | 18.2507 |
| 2000's | 16 (15.24) | 29.6817 |
| 2010's | 4 (3.81) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dimitrova-Karamfilova, A | 1 |
| Tzveova, R | 1 |
| Chilingirova, N | 1 |
| Goranova, T | 1 |
| Nachev, G | 1 |
| Mitev, V | 1 |
| Kaneva, R | 1 |
| Brand, AR | 1 |
| de Borst, GJ | 1 |
| Jamula, E | 1 |
| Douketis, JD | 1 |
| Schulman, S | 1 |
| González-Fajardo, JA | 1 |
| Martin-Pedrosa, M | 1 |
| Castrodeza, J | 1 |
| Tamames, S | 1 |
| Vaquero-Puerta, C | 1 |
| Kemkes-Matthes, B | 1 |
| Brenner, C | 1 |
| Huber, B | 1 |
| Becker, A | 1 |
| Ostermann, H | 1 |
| Becker, C | 1 |
| Steinbeck, G | 1 |
| Franz, WM | 1 |
| Reininghaus, EZ | 1 |
| Schmidt, H | 1 |
| Lafer, I | 1 |
| Gutjahr, G | 1 |
| Schmidt, SM | 1 |
| Reininghaus, B | 1 |
| Kapfhammer, HP | 1 |
| Stepan, V | 1 |
| Rutten, FH | 1 |
| Hak, E | 1 |
| Stalman, WA | 1 |
| Verheij, TJ | 1 |
| Hoes, AW | 1 |
| SCARRONE, LA | 1 |
| BECK, DF | 1 |
| WRIGHT, IS | 1 |
| KOLLER, F | 1 |
| SCHWENZER, AW | 1 |
| KONIG, FE | 1 |
| DE NICOLA, P | 1 |
| MILCH, E | 1 |
| BERMAN, L | 1 |
| EGAN, R | 1 |
| LUND, E | 3 |
| WOLFF, JM | 1 |
| BARKER, NW | 1 |
| GIFFORD, RW | 1 |
| MANN, FD | 1 |
| COOGAN, TJ | 1 |
| DAVIS, JA | 1 |
| PETERSEN, ES | 1 |
| KISTNER, RW | 1 |
| SMITH, GV | 1 |
| DEUTSCH, E | 1 |
| HUEBER, EF | 1 |
| MAYER, E | 1 |
| WOHLRAB, K | 1 |
| REIST, A | 1 |
| FRIES, K | 1 |
| STAMM, H | 1 |
| CHALMERS, JN | 1 |
| DIXON, MF | 1 |
| POLACK, W | 1 |
| GIPPERICH, G | 1 |
| BIRCHER, J | 1 |
| KAUFMANN, P | 1 |
| MATERNE, M | 1 |
| VON BRANDIS, HJ | 1 |
| LANGER, H | 1 |
| WITTE, S | 1 |
| DIRNBERGER, P | 1 |
| MEIXNER, H | 1 |
| RASSLER, R | 2 |
| GOOSSENS, N | 1 |
| RICHTER, F | 1 |
| WALCHER, A | 1 |
| AL'PERN, PM | 1 |
| LOGINOVA, FI | 1 |
| MALOVA, MV | 1 |
| OBE, G | 1 |
| STROBEL, E | 1 |
| LINDAHL, O | 1 |
| SCHILLING, FJ | 1 |
| KRUESI, OR | 1 |
| NANNINGA, HS | 2 |
| HANSEN, A | 2 |
| NEILSON, JM | 1 |
| MOLLISON, AW | 1 |
| NEILL, EC | 1 |
| MOON, RY | 1 |
| VANDER VEER, JB | 1 |
| FAIRBAIRN, JF | 1 |
| ESTES, JE | 1 |
| KRANEPUHL, F | 1 |
| ALEXANDER, F | 1 |
| KOPPEL, JL | 1 |
| ARSCOTT, PM | 1 |
| OLWIN, JH | 1 |
| BUSER, P | 1 |
| KNIEPKAMP, G | 1 |
| GUGGENBUHL-SCHMITTER, H | 1 |
| NICHOLSON, JH | 1 |
| PRIOR, I | 1 |
| KOSCH, L | 1 |
| PERRETTA, A | 1 |
| GUIDO, JJ | 1 |
| PARANO, JR | 1 |
| RASCOVAN, S | 1 |
| SANSUSTE, A | 1 |
| SHAPIRO, CM | 1 |
| LISKER, R | 1 |
| LICHTMAN, AM | 1 |
| JOSEPHSON, AM | 1 |
| CRAMER, W | 1 |
| POHLHAUS, E | 1 |
| THIES, HA | 1 |
| WASCHKE, G | 1 |
| UEBELHART, R | 1 |
| STRAULI, P | 1 |
| TOOHEY, M | 1 |
| PORTER, RR | 1 |
| RICHARDSON, D | 1 |
| MAUCK, HP | 1 |
| GUGGISBERG, W | 1 |
| MONTIGEL, C | 1 |
| HARRISON, CE | 1 |
| SPITTEL, JA | 1 |
| WAUGH, JM | 1 |
| KETTENBOURG, HK | 1 |
| JAPIKSE, JE | 1 |
| TOSTES, LR | 1 |
| RIBEIRO, AP | 1 |
| da RAPOSO, JS | 1 |
| SALES NETO, M | 1 |
| CUSTER, HR | 1 |
| MUSTARD, RL | 1 |
| TREIT, S | 1 |
| SZINNYAI, M | 1 |
| VARJASI, F | 1 |
| HUNKA, R | 1 |
| MALAGAMBA, G | 1 |
| ROTTGER, H | 1 |
| HALLEN, LG | 1 |
| HARTENBACH, W | 1 |
| DE VETTEN, AL | 1 |
| O'Donnell, M | 1 |
| Hirsh, J | 2 |
| Torn, M | 1 |
| van der Meer, FJ | 1 |
| Rosendaal, FR | 1 |
| LASSNER, J | 1 |
| Ansell, J | 2 |
| Bergqvist, D | 1 |
| Lee, AY | 1 |
| Rickles, FR | 1 |
| Julian, JA | 1 |
| Gent, M | 1 |
| Baker, RI | 1 |
| Bowden, C | 1 |
| Kakkar, AK | 1 |
| Prins, M | 1 |
| Levine, MN | 1 |
| Greaves, M | 1 |
| Penka, M | 1 |
| Buliková, A | 1 |
| Gumulec, J | 1 |
| Matýsková, M | 1 |
| Smejkal, P | 1 |
| Kissová, J | 1 |
| Slechtová, M | 1 |
| Chlupová, G | 1 |
| Sas, G | 1 |
| Herijgers, P | 1 |
| Verhamme, P | 1 |
| Stürzebecher, J | 1 |
| Huyke, R | 1 |
| Vogel, G | 1 |
| Sturzenegger, M | 1 |
| Beer, JH | 1 |
| Rihs, F | 1 |
| Monreal, M | 1 |
| Lafoz, E | 1 |
| Olive, A | 1 |
| del Rio, L | 1 |
| Vedia, C | 1 |
| Jansson, JH | 1 |
| Westman, G | 1 |
| Boman, K | 1 |
| Nilsson, T | 1 |
| Norberg, B | 1 |
| Hermes, B | 1 |
| Haas, N | 1 |
| Henz, BM | 1 |
| Dick, B | 1 |
| Jacobi, FK | 1 |
| Meschengieser, SS | 1 |
| Fondevila, CG | 1 |
| Frontroth, J | 1 |
| Santarelli, MT | 1 |
| Lazzari, MA | 1 |
| Voith, L | 1 |
| Pfliegler, G | 1 |
| Hegedús, I | 1 |
| Medgyesi, F | 1 |
| Bódi, A | 1 |
| Csapó, K | 1 |
| Boda, Z | 1 |
| Hyers, TM | 1 |
| Agnelli, G | 1 |
| Hull, RD | 1 |
| Weg, JG | 1 |
| Morris, TA | 1 |
| Samama, M | 1 |
| Tapson, V | 1 |
| Hellemons, BS | 1 |
| Langenberg, M | 1 |
| Lodder, J | 1 |
| Vermeer, F | 1 |
| Schouten, HJ | 1 |
| Lemmens, T | 1 |
| van Ree, JW | 1 |
| Knottnerus, JA | 1 |
| Stiefelhagen, P | 1 |
| Watzke, HH | 1 |
| Forberg, E | 1 |
| Svolba, G | 1 |
| Jimenez-Boj, E | 1 |
| Krinninger, B | 1 |
| Dalen, J | 1 |
| Anderson, DR | 1 |
| Poller, L | 1 |
| Bussey, H | 1 |
| Deykin, D | 1 |
| Salazar, E | 1 |
| Izaguirre, R | 1 |
| van Heusden, AM | 1 |
| Merkus, HM | 1 |
| Dullemond-Westland, AC | 1 |
| Wittstamm, FJ | 1 |
| Benesch, L | 1 |
| Ayhan, A | 1 |
| Yapar, EG | 1 |
| Yüce, K | 1 |
| Kişnişci, HA | 1 |
| Nazli, N | 1 |
| Ozmen, F | 1 |
| Kessler, CM | 1 |
| Martinowitz, U | 1 |
| Mazar, AL | 1 |
| Taicher, S | 1 |
| Varon, D | 1 |
| Gitel, SN | 1 |
| Ramot, B | 1 |
| Rakocz, M | 1 |
| Scheffler, P | 1 |
| Kiehl, R | 1 |
| Braun, B | 1 |
| Hellstern, P | 1 |
| Wenzel, E | 1 |
| Lie, JT | 1 |
| Duveau, D | 1 |
| Pabinger, I | 1 |
| Karnik, R | 1 |
| Lechner, K | 1 |
| Slany, J | 1 |
| Niessner, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Randomized, Phase III-b, Multi-centre, Open-label, Parallel Study of Enoxaparin (Low Molecular Weight Heparin) Given Concomitantly With Chemotherapy vs Chemotherapy Alone in Patients With Inoperable Gastric and Gastro-oesophageal Cancer[NCT00718354] | Phase 3 | 740 participants (Actual) | Interventional | 2008-07-31 | Completed | ||
| "Transcranial Doppler Assessment of Cerebral Embolization During Early Anti-thrombotic Therapy After Bioprosthetic Aortic Valve Replacement: Comparison of High-dose Aspirin Versus Warfarin Plus Low-dose Aspirin"[NCT00465218] | 56 participants (Actual) | Observational | 2007-03-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
9 reviews available for coumarin and Thromboembolism
| Article | Year |
|---|---|
Evidence for periprocedural antiplatelet therapy, heparinization and bridging of coumarin therapy in carotid revascularization.
Topics: Angioplasty; Anticoagulants; Carotid Stenosis; Coumarins; Endarterectomy, Carotid; Heparin; Humans; | 2017 |
Perioperative anticoagulation in patients having implantation of a cardiac pacemaker or defibrillator: a systematic review and practical management guide.
Topics: Anticoagulants; Coumarins; Defibrillators, Implantable; Hematoma; Heparin; Humans; Pacemaker, Artifi | 2008 |
Current options in the prevention of thromboembolic disease.
Topics: Administration, Oral; Anticoagulants; Coumarins; Fondaparinux; Heparin; Humans; Injections, Subcutan | 2004 |
[The preparation of a patient with long-term anticoagulant cumarin treatment for invasive surgery].
Topics: Anticoagulants; Coumarins; Hemorrhage; Humans; International Normalized Ratio; Postoperative Hemorrh | 2006 |
[Old burdens and new perspectives of the long-term anticoagulant therapy].
Topics: Anticoagulants; Azetidines; Benzylamines; Coumarins; Drug Administration Schedule; Hemorrhage; Hepar | 2006 |
Antithrombotic therapy for venous thromboembolic disease.
Topics: Coumarins; Fibrinolytic Agents; Heparin; Heparin, Low-Molecular-Weight; Humans; Pulmonary Embolism; | 1998 |
Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Coumarins; Drug Interactions; Food; Heart | 2001 |
[Heart disease, anticoagulants and pregnancy].
Topics: Abortion, Spontaneous; Adult; Anticoagulants; Coumarins; Female; Fetus; Gestational Age; Heart Valve | 2001 |
The pharmacology of aspirin, heparin, coumarin, and thrombolytic agents. Implications for therapeutic use in cardiopulmonary disease.
Topics: Aspirin; Coumarins; Fibrinolytic Agents; Heparin; Humans; Thromboembolism; Thrombolytic Therapy; Thr | 1991 |
7 trials available for coumarin and Thromboembolism
| Article | Year |
|---|---|
Effect of the anticoagulant therapy in the incidence of post-thrombotic syndrome and recurrent thromboembolism: Comparative study of enoxaparin versus coumarin.
Topics: Anticoagulants; Coumarins; Enoxaparin; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Ag | 2008 |
Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism.
Topics: Acute Disease; Administration, Oral; Aged; Anticoagulants; Coumarins; Dalteparin; Female; Heparin, L | 2005 |
Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications to coumarin.
Topics: Adult; Aged; Aged, 80 and over; Contraindications; Coumarins; Dalteparin; Female; Fractures, Spontan | 1994 |
Low-intensity oral anticoagulation plus low-dose aspirin versus high-intensity oral anticoagulation alone: a randomized trial in patients with mechanical prosthetic heart valves.
Topics: Anticoagulants; Aspirin; Coumarins; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; | 1997 |
[Coumarin combined with low-dose acetylsalicylic acid in the prevention of thromboembolic complications in patients with mitral and aortic valve prostheses].
Topics: Adolescent; Adult; Aged; Anticoagulants; Aortic Valve; Aspirin; Coumarins; Female; Heart Valve Prost | 1997 |
Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirin.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Coumarins; Female; Follow-Up Studies; Humans; Ma | 1999 |
A prospective controlled trial comparing weekly self-testing and self-dosing with the standard management of patients on stable oral anticoagulation.
Topics: Administration, Oral; Adult; Aged; Algorithms; Anticoagulants; Blood Coagulation; Case Management; C | 2000 |
89 other studies available for coumarin and Thromboembolism
| Article | Year |
|---|---|
ANTICOAGULANT therapy in congestive heart failure.
Topics: Anticoagulants; Coumarins; Heart Failure; Heparin; Humans; Thromboembolism | 1952 |
Acenocoumarol Pharmacogenetic Dosing Algorithms and Their Application in Two Bulgarian Patients with Low Anticoagulant Requirements.
Topics: Acenocoumarol; Algorithms; Anticoagulants; Aortic Valve; Bulgaria; Coumarins; Dose-Response Relation | 2015 |
[Anticoagulation by oral treatment with vitamin K antagonists].
Topics: Administration, Oral; Anticoagulants; Arrhythmias, Cardiac; Coumarins; Drug Interactions; Humans; In | 2008 |
Thromboembolism and coumarin overdosage in a 19-year-old female: impact of pharmacogenetics.
Topics: Coumarins; Drug Overdose; Female; Humans; Iliac Vein; International Normalized Ratio; Pharmacogeneti | 2010 |
Outcome of coumarin-therapy in an outpatient setting over a 10-year period: coumarin-therapy in clinical practice.
Topics: Aged; Aged, 80 and over; Ambulatory Care; Anticoagulants; Austria; Comorbidity; Coumarins; Drug-Rela | 2012 |
Is treatment of atrial fibrillation in primary care based on thromboembolic risk assessment?
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Coumarins; Cross-Sectional Studies; Evidence-Bas | 2003 |
A comparative evaluation of tromexan and dicumarol in the treatment of thromboembolic conditions--based on experience with 514 patients; a report of the Committee on Anticoagulants of the American Heart Association.
Topics: American Heart Association; Anticoagulants; Coumarins; Dicumarol; Ethyl Biscoumacetate; Thromboembol | 1952 |
[Recent progress in anticoagulant therapy of thromboembolism].
Topics: Anticoagulants; Blood Coagulation; Coumarins; Heparin; Humans; Thromboembolism | 1952 |
[Prophylaxis and therapy of thromboembolism].
Topics: Coumarins; Female; Genitalia; Genitalia, Female; Humans; Thromboembolism | 1953 |
[Treatment of thromboses and embolisms in obstetrics and gynecology with the liquemin-depot Roche and with tromexan].
Topics: Coumarins; Embolism; Ethyl Biscoumacetate; Gynecology; Heparin; Obstetrics; Thromboembolism; Thrombo | 1953 |
[Clinical significance of factor VII].
Topics: Blood Coagulation; Coumarins; Factor VII; Hemostatics; Heparin Antagonists; Humans; Infant, Newborn; | 1953 |
Use of bishydroxycoumarin (dicumarol) for prevention of postoperative thromboembolism; a study of twenty-seven hundred consecutive surgical patients.
Topics: Anticoagulants; Coumarins; Dicumarol; Humans; Patients; Postoperative Care; Postoperative Period; Th | 1953 |
[Prolonged dicumarol therapy of coronary thrombosis and other thromboembolic diseases].
Topics: Coronary Thrombosis; Coumarins; Dicumarol; Thromboembolism | 1953 |
Experience with a new intravenous coumarin anticoagulant (warfarin, sodium derivative).
Topics: Anticoagulants; Coumarins; Sodium; Sodium, Dietary; Thromboembolism; Warfarin | 1953 |
Experiences with the long range use of anticoagulant therapy.
Topics: Anticoagulants; Coumarins; Myocardial Infarction; Thromboembolism | 1953 |
Long term dicumarol therapy in thromboembolic conditions, especially coronary thrombosis.
Topics: Coronary Disease; Coronary Thrombosis; Coumarins; Dicumarol; Embolism; Thromboembolism | 1953 |
A ten year analysis of thromboembolism and dicumarol prophylaxis.
Topics: Coumarins; Dicumarol; Thromboembolism | 1954 |
[The therapeutic use of a new anticoagulant, marcoumar].
Topics: Anticoagulants; Coumarins; Myocardial Infarction; Phenprocoumon; Thromboembolism; Thrombophlebitis | 1954 |
[Tromexan in selective prevention of thrombo-embolic diseases in puerperium].
Topics: Anticoagulants; Coumarins; Embolism; Ethyl Biscoumacetate; Female; Humans; Postpartum Period; Thromb | 1954 |
[Marcoumar in general prevention of puerperal thrombosis].
Topics: Anticoagulants; Coumarins; Female; Humans; Phenprocoumon; Postpartum Period; Puerperal Disorders; Th | 1954 |
[Experience with tromexan].
Topics: Coumarins; Ethyl Biscoumacetate; Thromboembolism | 1954 |
Antagonistic effect of oral vitamin K1 on the action of ethyl biscoumacetate and phenylindanedione.
Topics: Antifibrinolytic Agents; Coumarins; Ethyl Biscoumacetate; Heparin Antagonists; Naphthoquinones; Phen | 1954 |
[Individual postoperative thrombosis control in prevention of early embolism].
Topics: Coumarins; Embolism; Humans; Postoperative Period; Procaine; Surgical Procedures, Operative; Thrombo | 1954 |
[Experiences in prevention of thromboembolism].
Topics: Anticoagulants; Biomedical Research; Coumarins; Humans; Thromboembolism | 1954 |
[Dicumacyl in prevention of thromboembolic complications after gynecologic and obstetric operations].
Topics: Biomedical Research; Coumarins; Female; Obstetric Surgical Procedures; Pregnancy; Thromboembolism | 1955 |
For Thromboembolism Prophylaxis with Anticoagulants, Especially Marcumar.
Topics: Anticoagulants; Coumarins; Humans; Thromboembolism | 1955 |
[Anticoagulant therapy with marcumar].
Topics: Anticoagulants; Coumarins; Phenprocoumon; Thromboembolism | 1954 |
[Antithrombic coagulation factors in thromboembolism].
Topics: Blood Coagulation; Blood Coagulation Factors; Coumarins; Humans; Thrombin; Thromboembolism | 1955 |
[Specific treatment of thromboembolism in obstetrics and gynecology].
Topics: Anticoagulants; Coumarins; Female; Genital Diseases, Female; Gynecology; Heparin; Humans; Obstetrics | 1955 |
[Reduction on the frequency of thromboembolism by general prophylaxis with anticoagulants].
Topics: Anticoagulants; Coumarins; Surgical Procedures, Operative; Thromboembolism | 1955 |
[The thromboembolism-preventing properties of a new coumarin derivative, sintrom].
Topics: Acenocoumarol; Anticoagulants; Coumarins; Thromboembolism | 1955 |
[Experience in using neodecumarin for prevention of thromboembolic complications in hypertension].
Topics: Biomedical Research; Coumarins; Humans; Hypertension; Thromboembolism; Vascular Diseases | 1956 |
[Clinical results with the anticoagulant sintrom (G 23350)].
Topics: Acenocoumarol; Anticoagulants; Coumarins; Thromboembolism | 1956 |
[Results of specific treatment of thromboembolism with anticoagulants cumid and athrombon].
Topics: Anticoagulants; Coumarins; Thromboembolism | 1955 |
[Clinical studies on sintrom (G 23350), a new anticoagulant].
Topics: Acenocoumarol; Anticoagulants; Coumarins; Humans; Thromboembolism | 1956 |
[Thrombotic diseases, especially treatment with tromexan].
Topics: Coumarins; Ethyl Biscoumacetate; Thromboembolism; Thrombosis | 1956 |
[Marcoumar treatment of thromboembolic conditions].
Topics: Coumarins; Phenprocoumon; Thromboembolism | 1956 |
Clinical evaluation of acenocoumarin, a new 4-hydroxycoumarin anticoagulant.
Topics: 4-Hydroxycoumarins; Acenocoumarol; Anticoagulants; Coumarins; Thromboembolism | 1956 |
[Clinical experiences with the anticoagulant sintrom].
Topics: Acenocoumarol; Anticoagulants; Coumarins; Thromboembolism | 1956 |
[Clinical experiences with the anticoagulant sintrom].
Topics: Acenocoumarol; Anticoagulants; Coumarins; Thromboembolism | 1956 |
[Clinical experiences with the anticoagulant sintrom].
Topics: Acenocoumarol; Anticoagulants; Coumarins; Thromboembolism | 1956 |
[Clinical experiences with the anticoagulant sintrom].
Topics: Acenocoumarol; Anticoagulants; Coumarins; Thromboembolism | 1956 |
[Prevention of thromboembolism after gynecological surgery with marcumar, a coumarin derivative].
Topics: Coumarins; Female; Genitalia; Genitalia, Female; Gynecologic Surgical Procedures; Humans; Phenprocou | 1956 |
[Prevention of thromboembolism after gynecological surgery with marcumar, a coumarin derivative].
Topics: Coumarins; Female; Genitalia; Genitalia, Female; Gynecologic Surgical Procedures; Humans; Phenprocou | 1956 |
[Prevention of thromboembolism after gynecological surgery with marcumar, a coumarin derivative].
Topics: Coumarins; Female; Genitalia; Genitalia, Female; Gynecologic Surgical Procedures; Humans; Phenprocou | 1956 |
[Prevention of thromboembolism after gynecological surgery with marcumar, a coumarin derivative].
Topics: Coumarins; Female; Genitalia; Genitalia, Female; Gynecologic Surgical Procedures; Humans; Phenprocou | 1956 |
Clinical evaluation of three anticoagulants in thrombo-embolic disease.
Topics: Anticoagulants; Coumarins; Embolism; Ethyl Biscoumacetate; Humans; Phenindione; Prothrombin Time; Th | 1957 |
Clinical evaluation of a new oral anticoagulant sintrom.
Topics: Acenocoumarol; Anticoagulants; Coumarins; Thromboembolism | 1957 |
Clinical experience with 3-(1-phenylpropyl)-4-hydroxycoumarin.
Topics: 4-Hydroxycoumarins; Coumarins; Dicumarol; Ethyl Biscoumacetate; Humans; Thromboembolism | 1957 |
[Postoperative thromboses & embolisms; causes, prophylaxis & treatment].
Topics: Coumarins; Embolism; Ethyl Biscoumacetate; Humans; Surgical Procedures, Operative; Thromboembolism | 1957 |
Clinical experience with the anticoagulant acenocoumarin (sintrom).
Topics: Acenocoumarol; Anticoagulants; Coumarins; Thromboembolism | 1957 |
[Limitations of prophylaxis of thrombosis & embolism].
Topics: Aminobenzoates; Anticoagulants; Coumarins; Embolism; Humans; Thromboembolism | 1957 |
[Experience in postoperative prevention and therapy of thromboembolism with special reference to the double test; Quick test and heparin tolerance test].
Topics: Coumarins; Female; Genitalia; Genitalia, Female; Heparin; Humans; Prothrombin Time; Thromboembolism | 1957 |
[Experience with specific medical thromboembolism prevention in St. Gallen Women's Clinic].
Topics: Anticoagulants; Coumarins; Humans; Thromboembolism | 1957 |
Clinical experiences with anticoagulants; a comparison of coumadin (warfarin) sodium and dicumarol (bishydroxycoumarin).
Topics: Anticoagulants; Coumarins; Dicumarol; Sodium; Thromboembolism; Warfarin | 1957 |
Anticoagulant studies with dicoumarol and marcoumar; control achieved and applications.
Topics: Anticoagulants; Coumarins; Dicumarol; Humans; Phenprocoumon; Thromboembolism | 1957 |
[Three years of experience with medicinal postoperative thrombosis prevention].
Topics: Anticoagulants; Coumarins; Heparin; Humans; Thromboembolism | 1957 |
[Use of dicumarol derivatives in diseases of the blood vessels].
Topics: Coumarins; Dicumarol; Ethyl Biscoumacetate; Humans; Thromboembolism | 1957 |
Comparative clinical study of coumadin sodium and dicumarol in patients with thromboembolic diseases.
Topics: Coumarins; Dicumarol; Humans; Sodium; Sodium, Dietary; Thromboembolism; Warfarin | 1958 |
[Experiences with a general thrombosis preventative with a report of results of more than 3000 treatments with marcumar].
Topics: Anticoagulants; Coumarins; Humans; Phenprocoumon; Thromboembolism; Thrombosis | 1958 |
[Control of coumarin effects by clinical procedures].
Topics: Anticoagulants; Coumarins; Humans; Thromboembolism | 1957 |
[Contribution to general thrombosis prophylaxis after gynecological operations].
Topics: Anticoagulants; Coumarins; Genitalia; Genitalia, Female; Thromboembolism; Thrombosis | 1957 |
[Prophylaxis and therapy with the anticoagulant sintrom in gynecology and obstetrics].
Topics: Acenocoumarol; Anticoagulants; Coumarins; Female; Genitalia; Genitalia, Female; Gynecology; Humans; | 1958 |
Clinical experience with warfarin sodium.
Topics: Coumarins; Thromboembolism; Warfarin | 1958 |
Clinical experiences with the anticoagulant warfarin sodium (coumadin sodium).
Topics: Anticoagulants; Coumarins; Sodium; Thromboembolism; Warfarin | 1958 |
[Experience with butazolidin-sintrom combined prevention & butazolidine prevention Of thromboembolic disease].
Topics: Acenocoumarol; Anticoagulants; Coumarins; Phenylbutazone; Thromboembolism | 1958 |
Coumarin anticoagulant therapy of patients with T-tube drainage of the common bile duct.
Topics: Anticoagulants; Cholelithiasis; Common Bile Duct; Coumarins; Drainage; Hemorrhage; Humans; Thromboem | 1961 |
[The treatment of thromboembolic processes with a combination of heparin and coumarin preparations].
Topics: Anticoagulants; Coumarins; Heparin; Thromboembolism | 1961 |
[Study of a new coumarin anticoagulant, compound G-23350 (Sintrom)].
Topics: Acenocoumarol; Anticoagulants; Coronary Disease; Coumarins; Peripheral Vascular Diseases; Thromboemb | 1960 |
Six years experience with dicumarol prophylaxis against postoperative thromboembolic complications in private practice.
Topics: Anticoagulants; Coumarins; Dicumarol; Humans; Postoperative Care; Postoperative Complications; Priva | 1955 |
[Pelentan treatment of thromboembolism following a gynecological operation].
Topics: Coumarins; Ethyl Biscoumacetate; Female; Genital Diseases, Female; Gynecologic Surgical Procedures; | 1954 |
[Anticoagulant prophylaxis with marcoumar in the puerperium].
Topics: Anticoagulants; Coumarins; Female; Humans; Phenprocoumon; Postpartum Period; Thromboembolism | 1955 |
[Thromboembolism prophylaxis in surgical gynecology with a coumarin derivative and its antagonist vitamin K1].
Topics: Anticoagulants; Coumarins; Female; Genitalia; Genitalia, Female; Gynecology; Humans; Thromboembolism | 1955 |
[Early therapy or prevention of thromboembolism].
Topics: Biomedical Research; Coumarins; Heparin; Humans; Secondary Prevention; Thromboembolism | 1951 |
[Therapeutic effectiveness of dicumarol suppositories].
Topics: Anticoagulants; Coumarins; Dicumarol; Humans; Suppositories; Thromboembolism | 1951 |
Treatment and prophylaxis of thrombosis and embolism with dicumacyl; problems and results.
Topics: Coumarins; Embolism; Humans; Thromboembolism; Thrombosis | 1952 |
Establishing an optimal therapeutic range for coumarins: filling in the gaps.
Topics: Anticoagulants; Coumarins; Hemorrhage; Humans; International Normalized Ratio; Thromboembolism; Warf | 2004 |
Lowering the intensity of oral anticoagulant therapy: effects on the risk of hemorrhage and thromboembolism.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Brain Ischemia; Coumarins; Female; Heart Valve Prosthesis | 2004 |
[Prevention of postoperative thromboembolic complications].
Topics: Biomedical Research; Coumarins; Humans; Postoperative Complications; Thromboembolism | 1952 |
Pharmacogenetics in the management of coumarin anticoagulant therapy: the way forward or an expensive diversion?
Topics: Anticoagulants; Cost-Benefit Analysis; Coumarins; Dose-Response Relationship, Drug; Drug Resistance; | 2005 |
Improving the quality of anticoagulant therapy in patients with mechanical heart valves: what are we waiting for?
Topics: Administration, Oral; Anticoagulants; Aortic Valve; Coumarins; Heart Valve Prosthesis; Humans; Inter | 2007 |
[Determination of factor XII, plasma prekallikrein and factor V in patients with thrombophilic states].
Topics: Blood Coagulation Tests; Coumarins; Factor V; Factor XII; Glycoproteins; Humans; Kallikreins; Prekal | 1984 |
Monitoring combined antithrombotic treatments in patients with prosthetic heart valves using transcranial Doppler and coagulation markers.
Topics: Administration, Oral; Adult; Antithrombin III; Aspirin; beta-Thromboglobulin; Biomarkers; Coumarins; | 1995 |
Oral anticoagulant treatment in a medical care district--a descriptive study.
Topics: Administration, Oral; Anticoagulants; Coumarins; Female; Hemorrhage; Humans; Male; Monitoring, Ambul | 1995 |
Immunopathological events of adverse cutaneous reactions to coumarin and heparin.
Topics: Coumarins; Drug Eruptions; Female; Heparin; Humans; Middle Aged; Necrosis; Skin; Thromboembolism; Tu | 1997 |
[Cataract surgery and anticoagulation--current status].
Topics: Anticoagulants; Aspirin; Blood Loss, Surgical; Cataract Extraction; Coumarins; Heparin; Humans; Pati | 1996 |
[Good therapy control requires a standardized test. Thrombosis ABC, 13: INR instead of Quick].
Topics: Anticoagulants; Coumarins; Humans; International Normalized Ratio; Long-Term Care; Predictive Value | 2000 |
Pregnancy and protein C deficiency.
Topics: Adult; Coumarins; Female; Fetal Death; Heparin; Humans; Pregnancy; Pregnancy Complications, Hematolo | 1992 |
[Reliable Quick value management by self determination].
Topics: Coumarins; Heart Valve Prosthesis; Humans; Postoperative Complications; Prothrombin Time; Risk Facto | 1992 |
Pregnancy and its complications after cardiac valve replacement.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Adult; Coumarins; Female; Fetal Death; Heart Val | 1991 |
Dental extraction for patients on oral anticoagulant therapy.
Topics: Administration, Oral; Adult; Aged; Anticoagulants; Coumarins; Dental Care for Disabled; Fibrin Tissu | 1990 |
[Thromboembolism complications and coumarin necrosis in a patient with congenital antithrombin III deficiency].
Topics: Adult; Antithrombin III Deficiency; Coumarins; Female; Humans; Ischemia; Necrosis; Pedigree; Thrombo | 1988 |
Recurrent thromboembolism, disseminated intravascular coagulation, and coumarin-induced skin necrosis associated with protein C deficiency.
Topics: Adolescent; Blood Coagulation; Coumarins; Disseminated Intravascular Coagulation; Female; Gangrene; | 1988 |
Anticoagulation is necessary in all patients with mechanical prostheses in sinus rhythm.
Topics: Anticoagulants; Bioprosthesis; Coumarins; Drug Therapy, Combination; Heart Valve Diseases; Heart Val | 1986 |
Coumarin induced acral skin necrosis associated with hereditary protein C deficiency.
Topics: Adult; Antigen-Antibody Complex; Cesarean Section; Complement C4; Coumarins; Female; Glycoproteins; | 1986 |